Defence Therapeutics Inc.

C$0.35As of Sun 8 Nov 2026, 12:00 UTC
CSE:DTCHealthcare
Country Canada
PE (Fwd) •••
TSR 5Y CAGR (38.21%)
Div yield —
ROE (594.03%)
Biotechnology
Beta (5Y) 1.50
PE TTM —
TSR TTM (53.90%)
Mkt cap C$26.90M
ROIC (112.55%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.383
7.85%
(52.83%)
Hold 10|2|5|12|5
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
0.01
0.01
(3.07%)
0.48%
10.42%
10.09%
Revenue$M
1.360
1.438
1.469
1.466
12.59%
13.86%
10.55%
12.10%
Peers (US$19.04M)
Cap (US$)
PE
19.32M
—
18.28M
—
Capital
TTM
5Y
10Y
Leveragex
1.722
(0.189)
(0.166)
EBIT/Intx
1.587
0.328
0.334
Own earn%
8.12
(48.12)
(40.77)
Sh yield%
20.11
45.83
46.83
Owners
Insiders/Inst%
13.08
37.45
Short interest%
4.27
SBC / revenue%
4.17
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
15–22
$1 testx
−0.5
Incr. ROIC%
7